Author:
Li Ying,Weng Youliang,Huang Zongwei,Pan Yuhui,Cai Sunqin,Ding Qin,Wu Zijie,Chen Xin,Lu Jun,Hu Dan,Qiu Sufang
Abstract
Abstract
Background
We aimed to evaluate the optimal management for elderly patients with nasopharyngeal carcinoma (NPC) with intensity-modulated radiotherapy (IMRT).
Methods
A total of 283 elderly patients with NPC diagnosed from 2015 to 2019 were enrolled in the study. Overall survival (OS) was the primary endpoint. Univariate and multivariate Cox regression analyses were preformed to identify potential prognostic factors. The recursive partitioning analysis (RPA) was used for risk stratification. Kaplan-Meier survival curves were applied to evaluate the survival endpoints, and log-rank test was utilized to assess differences between groups. The prognostic index (PI) was constructed to further predict patients’ prognosis displayed by nomogram model. The area under the receiver operating characteristic (ROC) curves (AUC) and the calibration curves were applied to assess the effectiveness of the model.
Results
Based on RPA-based risk stratification, we demonstrated that elderly NPC patients who were treated with IC followed by RT had similar OS as those with induction chemotherapy (IC) combined with concurrent chemoradiotherapy (CCRT) in the middle- (stage I-III and pre-treatment EBV > 1840 copies/ml) and high-risk groups (stage IVA). IMRT alone may be the optimal treatment option for the low-risk group (stage I-III with pre-treatment EBV ≤ 1840 copies/ml). We established an integrated PI which was indicted with stronger prognostic power than each of the factors alone for elderly NPC patients (The AUC of PI was 0.75, 0.80, and 0.82 for 1-, 3-, 5-year prediction of OS, respectively).
Conclusion
We present a robust model for clinical stratification which could guide individual therapy for elderly NPC patients.
Funder
Innovative Medicine Subject of Fujian Provincial Health Commission, China
Major Research Projects for Young and Middle-aged Health Researchers of Fujian Province, China
National Natural Science Foundation of China
Joint Funds for the Innovation of Science and Technology,Fujian Province
High-level Talent Training Program of Fujian Cancer Hospital
Science and Technology Pilot Program of Fujian Province, China
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference50 articles.
1. Zhang LF, Li YH, Xie SH, et al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer. 2015;34(8):350–7.
2. Bossi P, Chan AT, Licitra L, et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(4):452–65.
3. Oubaya N, Soubeyran P, Reinald N, et al. Prognostic value of routinely measured inflammatory biomarkers in older cancer patients: Pooled analysis of three cohorts. Cancers. 2021;13(24):6154.
4. Lyu Y, Ni M, Zhai R, et al. Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Eur Arch Otorhinolaryngol. 2021;278(7):2549–57.
5. Wong KCW, Hui EP, Lo KW, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18(11):679–95.